THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
Patent Owner
Stats
- 568 US PATENTS IN FORCE
- 109 US APPLICATIONS PENDING
- Mar 13, 2018 most recent publication
Details
- 568 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 35,484 Total Citation Count
- Aug 18, 1982 Earliest Filing
- 689 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0051,083 BI-SPECIFIC ANTIBODIES AGAINST TIM-3 AND PD-1 FOR IMMUNOTHERAPY IN CHRONIC IMMUNE CONDITIONSNov 03, 17Feb 22, 18[A61K, C07K]
2018/0021,455 RECEPTOR-TARGETED NANOPARTICLES FOR ENHANCED TRANSCYTOSIS MEDIATED DRUG DELIVERYAug 31, 17Jan 25, 18[A61K, C07K]
2018/0000,066 Platelet Protection Solution Having Beta-Galactosidase and Sialidase InhibitorsSep 13, 17Jan 04, 18[A01N]
2017/0349,950 T CELL BALANCE GENE EXPRESSION, COMPOSITIONS OF MATTERS AND METHODS OF USE THEREOFAug 25, 17Dec 07, 17[C12Q, G01N]
2017/0333,348 MASS PRODUCTION AND SIZE CONTROL OF NANOPARTICLES THROUGH CONTROLLED MICROVORTICESJun 08, 17Nov 23, 17[A61K]
2017/0334,977 Targeting Apolipoprotein E (APOE) in Neurologic DiseaseOct 20, 15Nov 23, 17[C12N, C07K]
2017/0327,578 ANTI-CEACAM1 RECOMBINANT ANTIBODIES FOR CANCER THERAPYDec 20, 16Nov 16, 17[A61K, C07K]
2017/0319,500 SELF-ASSEMBLED GELS FOR CONTROLLED DELIVERY OF BIOLOGICS AND LABILE AGENTSMay 08, 17Nov 09, 17[A61K, A61M]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0342,109 Natural IGM Antibodies and Inhibitors ThereofAbandonedMay 08, 17Nov 30, 17[A61K, C07K]
2017/0000,899 RECEPTOR-TARGETED NANOPARTICLES FOR ENHANCED TRANSCYTOSIS MEDIATED DRUG DELIVERYAbandonedNov 25, 14Jan 05, 17[A61K, C07K]
2016/0274,043 Enhanced 13C NMR by Thermal Mixing with Hyperpolarized 129XEAbandonedMar 17, 16Sep 22, 16[G01N]
2016/0237,430 ALLELE-SPECIFIC RNA SILENCING FOR THE TREATMENT OF HYPERTROPHIC CARDIOMYOPATHYAbandonedSep 23, 14Aug 18, 16[C12N]
2016/0228,550 COMPOSITIONS AND METHODS OF PROPHYLAXIS FOR CONTACT DERMATITISAbandonedApr 14, 16Aug 11, 16[A61K]
2016/0129,030 TREATMENT OF MTOR HYPERACTIVE RELATED DISEASES AND DISORDERSAbandonedJun 11, 14May 12, 16[A61K, G01N, A61N]
2016/0115,549 Diagnosing and Monitoring CNS Malignancies Using MicroRNAAbandonedOct 05, 15Apr 28, 16[A61K, C12Q]
2016/0031,874 SUBSTITUTED AMINOTHIAZOLES FOR THE TREATMENT OF TUBERCULOSISAbandonedMar 13, 14Feb 04, 16[C07D]
2016/0022,727 IMMUNOMODULATING COMPOUNDS AND RELATED COMPOSITIONS AND METHODSAbandonedFeb 25, 15Jan 28, 16[A61K]
2015/0362,497 Autoantibody Signature for the Early Detection of Ovarian CancerAbandonedJan 30, 14Dec 17, 15[G01N]
2015/0355,185 USING GALECTIN-BINDING CARBOHYDRATES AS PREDICTORS OF MELANOMA PROGRESSION AND METASTASISAbandonedJan 16, 14Dec 10, 15[G01N]
2015/0346,100 METABOLIC IMAGING METHODS FOR ASSESSMENT OF OOCYTES AND EMBRYOSAbandonedJan 07, 14Dec 03, 15[G01N]
2015/0343,023 METHODS FOR CARDIOPROTECTION AND CARDIOREGENERATION WITH DIMERS OF EGF FAMILY LIGANDSAbandonedMay 11, 15Dec 03, 15[A61K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
